DS
PRQR icon

David Shaw’s ProQR Therapeutics PRQR Stock Holding History

David Shaw’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-110,552
Closed -$86K – 5456
2022
Q2 		$86K Buy
+110,552
New +$82.4K ﹤0.01% 4756
2022
Q1 		– Sell
-33,682
Closed -$270K – 5851
2021
Q4 		$270K Buy
+33,682
New +$256K ﹤0.01% 4728
2021
Q1 		– Sell
-12,591
Closed -$53K – 4410
2020
Q4 		$53K Sell
12,591
-5,940
-32% -$25.1K ﹤0.01% 3846
2020
Q3 		$89K Buy
18,531
+907
+5% +$4.74K ﹤0.01% 3716
2020
Q2 		$107K Sell
17,624
-7,760
-31% -$41.9K ﹤0.01% 3875
2020
Q1 		$139K Sell
25,384
-25,606
-50% -$196K ﹤0.01% 3732
2019
Q4 		$506K Buy
+50,990
New +$397K ﹤0.01% 3391
2019
Q1 		– Sell
-21,436
Closed -$338K – 3858
2018
Q4 		$338K Sell
21,436
-49,250
-70% -$904K ﹤0.01% 3291
2018
Q3 		$1.37M Buy
+70,686
New +$751K ﹤0.01% 2469
2016
Q2 		– Sell
-11,663
Closed -$57K – 3490
2016
Q1 		$57K Sell
11,663
-13,713
-54% -$69.7K ﹤0.01% 3328
2015
Q4 		$220K Sell
25,376
-5,545
-18% -$63.8K ﹤0.01% 3516
2015
Q3 		$451K Sell
30,921
-8,072
-21% -$135K ﹤0.01% 3127
2015
Q2 		$650K Buy
38,993
+23,187
+147% +$437K ﹤0.01% 3004
2015
Q1 		$346K Buy
+15,806
New +$326K ﹤0.01% 3241

Other funds holding PRQR

PFM
Privium Fund Management Amsterdam, Netherlands $544M AUM 72.49% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $580M AUM 29.81% 1-Year Est. Return
MCM
M28 Capital Management Stamford, Connecticut $47.2M AUM 32.31% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $524M AUM 164.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

David Shaw's PRQR Position: Q3 2022 in Review

David Shaw sold out of ProQR Therapeutics (PRQR) in Q3 2022, closing a stake of 110,552 shares — an estimated $86K sold.

David Shaw first reported a position in PRQR in Q1 2015 and held it in 14 quarters. The position peaked at $1.37M in Q3 2018. 47 funds tracked by Wall St. Rank hold PRQR as of Q3 2022.

  • David Shaw reported no remaining ProQR Therapeutics position as of Q3 2022 after selling out during the quarter.
  • David Shaw sold 110,552 ProQR Therapeutics shares in Q3 2022, an estimated $86K.
  • David Shaw first reported a position in ProQR Therapeutics in Q1 2015 and held it in 14 quarters.
  • David Shaw's ProQR Therapeutics position peaked at $1.37M in Q3 2018.
  • 47 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.